RNAi Creates Novel Court Filings; Tekmira In Trade Secrets Dispute With AlCana
A British Columbia court orders AlCana to return thousands of documents it allegedly downloaded from Tekmira’s electronic document management system. The claim arose from Tekmira’s suit against Alnylam and AlCana alleging trade secrets theft.
You may also be interested in...
Alnylam is paying Tekmira $65 million to resolve an RNAi trade secrets suit; the new licensing pact reduces Alnylam’s future milestone and royalty payments on three compounds and allows the firm to manufacture its own drug candidates.
After an expensive foray into RNAi, Roche is handing off its substantial portfolio to Arrowhead, in exchange for a 10% stake in the company and right-of-first-negotiation to programs and earn-out potential.
Suit alleges Alnylam stole Tekmira's RNAi delivery technology, but Alnylam dismisses the claims and says its delivery technology falls within its licensing agreement or other partnerships.